PortfoliosLab logo
ANDE vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ANDE and LLY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

ANDE vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Andersons, Inc. (ANDE) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%December2025FebruaryMarchAprilMay
983.30%
5,143.75%
ANDE
LLY

Key characteristics

Sharpe Ratio

ANDE:

-0.82

LLY:

-0.06

Sortino Ratio

ANDE:

-1.47

LLY:

0.21

Omega Ratio

ANDE:

0.83

LLY:

1.03

Calmar Ratio

ANDE:

-0.81

LLY:

-0.05

Martin Ratio

ANDE:

-1.98

LLY:

-0.11

Ulcer Index

ANDE:

19.20%

LLY:

12.37%

Daily Std Dev

ANDE:

40.18%

LLY:

37.94%

Max Drawdown

ANDE:

-81.75%

LLY:

-68.27%

Current Drawdown

ANDE:

-42.06%

LLY:

-21.46%

Fundamentals

Market Cap

ANDE:

$1.30B

LLY:

$737.66B

EPS

ANDE:

$3.33

LLY:

$12.27

PE Ratio

ANDE:

11.45

LLY:

66.95

PEG Ratio

ANDE:

2.93

LLY:

1.33

PS Ratio

ANDE:

0.11

LLY:

15.05

PB Ratio

ANDE:

0.95

LLY:

46.91

Total Revenue (TTM)

ANDE:

$8.54B

LLY:

$49.00B

Gross Profit (TTM)

ANDE:

$571.77M

LLY:

$40.03B

EBITDA (TTM)

ANDE:

$309.99M

LLY:

$16.67B

Returns By Period

In the year-to-date period, ANDE achieves a -14.28% return, which is significantly lower than LLY's -2.49% return. Over the past 10 years, ANDE has underperformed LLY with an annualized return of 0.03%, while LLY has yielded a comparatively higher 28.61% annualized return.


ANDE

YTD

-14.28%

1M

-5.73%

6M

-27.92%

1Y

-31.97%

5Y*

21.35%

10Y*

0.03%

LLY

YTD

-2.49%

1M

3.47%

6M

-5.45%

1Y

-2.41%

5Y*

39.23%

10Y*

28.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ANDE vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANDE
The Risk-Adjusted Performance Rank of ANDE is 66
Overall Rank
The Sharpe Ratio Rank of ANDE is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of ANDE is 77
Sortino Ratio Rank
The Omega Ratio Rank of ANDE is 99
Omega Ratio Rank
The Calmar Ratio Rank of ANDE is 55
Calmar Ratio Rank
The Martin Ratio Rank of ANDE is 11
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 4747
Overall Rank
The Sharpe Ratio Rank of LLY is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 4444
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 4343
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 4848
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ANDE vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Andersons, Inc. (ANDE) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ANDE Sharpe Ratio is -0.82, which is lower than the LLY Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of ANDE and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50December2025FebruaryMarchAprilMay
-0.82
-0.06
ANDE
LLY

Dividends

ANDE vs. LLY - Dividend Comparison

ANDE's dividend yield for the trailing twelve months is around 2.24%, more than LLY's 0.72% yield.


TTM20242023202220212020201920182017201620152014
ANDE
The Andersons, Inc.
2.24%1.41%1.29%2.07%1.82%2.86%2.71%2.22%2.07%1.40%1.82%0.88%
LLY
Eli Lilly and Company
0.72%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%2.84%

Drawdowns

ANDE vs. LLY - Drawdown Comparison

The maximum ANDE drawdown since its inception was -81.75%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for ANDE and LLY. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-42.06%
-21.46%
ANDE
LLY

Volatility

ANDE vs. LLY - Volatility Comparison

The current volatility for The Andersons, Inc. (ANDE) is 17.70%, while Eli Lilly and Company (LLY) has a volatility of 22.38%. This indicates that ANDE experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%December2025FebruaryMarchAprilMay
17.70%
22.38%
ANDE
LLY

Financials

ANDE vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between The Andersons, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
3.12B
12.73B
(ANDE) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

ANDE vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between The Andersons, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20212022202320242025
6.8%
82.5%
(ANDE) Gross Margin
(LLY) Gross Margin
ANDE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Andersons, Inc. reported a gross profit of 213.11M and revenue of 3.12B. Therefore, the gross margin over that period was 6.8%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

ANDE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Andersons, Inc. reported an operating income of 65.96M and revenue of 3.12B, resulting in an operating margin of 2.1%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

ANDE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Andersons, Inc. reported a net income of 45.09M and revenue of 3.12B, resulting in a net margin of 1.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.